A Pilot Study of SPG Block for PTSD

Completed · Early Phase 1

Conditions studied: Post Traumatic Stress Disorder

In brief

Some patients with Post Traumatic Stress Disorder (PTSD) respond only partially to medication. This study is a pilot study investigating whether blocking the SPG helps reduce the symptoms of PTSD. This study does not involve treatment with medications. It is a proof of principal study.

Key facts

Study ID

NCT05743543

Run by

New York State Psychiatric Institute

People needed

6

Starts

2019-05-28

Expected to finish

2023-06-01

Last updated by the study team

2024-02-16

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants with a principal diagnosis of PTSD on stable dose of psychiatric medication or in stable psychotherapy for at least 3 months, who experience residual symptoms.
• Participants who understand all study procedures and can undergo informed consent

You may not qualify if…

• Participants with a medical disorder, for whom study participation could be deleterious (neurologic, cardiac, renal or infectious disease)
• Pregnant or breast feeding participants
• Participants who are on an anticoagulant, such as warfarin, or otherwise have a medical condition that increases bleeding risk

Where it is running

• NYSPI — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.